Literature DB >> 24226152

Influence of single nucleotide polymorphisms on thrombin generation in factor V Leiden heterozygotes.

O Segers, P Simioni, D Tormene, E Castoldi1.   

Abstract

Carriership of the factor V (FV) Leiden mutation increases the risk of venous thromboembolism (VTE) ~4-fold, but the individual risk of each FV Leiden carrier depends on several co-inherited risk and protective factors. Under the hypothesis that thrombin generation might serve as an intermediate phenotype to identify genetic modulators of VTE risk, we enrolled 188 FV Leiden heterozygotes (11 with VTE) and determined the following parameters: thrombin generation in the absence and presence of activated protein C (APC); plasma levels of prothrombin, factor X, antithrombin, protein S and tissue factor pathway inhibitor; and the genotypes of 24 SNPs located in the genes encoding these coagulation factors and inhibitors. Multiple regression analysis was subsequently applied to identify the (genetic) determinants of thrombin generation. The endogenous thrombin potential (ETP) showed a striking inter-individual variability among different FV Leiden carriers and, especially when measured in the presence of APC, correlated with VTE risk. Several SNPs in the F2 (rs1799963, rs3136516), F10 (rs693335), SERPINC1 (rs2227589), PROS1 (Heerlen polymorphism) and TFPI (rs5940) genes significantly affected the ETP-APC and/or the ETP+APC in FV Leiden carriers. Most of these SNPs have shown an association with VTE risk in conventional epidemiological studies, suggesting that the genetic dissection of thrombin generation leads to the detection of clinically relevant SNPs. In conclusion, we have identified several SNPs that modulate thrombin generation in FV Leiden heterozygotes. These SNPs may help explain the large variability in VTE risk observed among different FV Leiden carriers.

Entities:  

Keywords:  Factor V Leiden; intermediate phenotype; single nucleotide polymorphism; thrombin generation; venous thromboembolism

Mesh:

Substances:

Year:  2013        PMID: 24226152     DOI: 10.1160/TH13-05-0360

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN: 0340-6245            Impact factor:   5.249


  4 in total

1.  Kallikrein augments the anticoagulant function of the protein C system in thrombin generation.

Authors:  Jun Wan; Nadira Vadaq; Joke Konings; Martin Jaeger; Vinod Kumar; Bas de Laat; Leo Joosten; Mihai G Netea; Andre J van der Ven; Philip G de Groot; Quirijn de Mast; Mark Roest
Journal:  J Thromb Haemost       Date:  2021-09-28       Impact factor: 16.036

2.  Tumor expression, plasma levels and genetic polymorphisms of the coagulation inhibitor TFPI are associated with clinicopathological parameters and survival in breast cancer, in contrast to the coagulation initiator TF.

Authors:  Mari Tinholt; Hans Kristian Moen Vollan; Kristine Kleivi Sahlberg; Sandra Jernström; Fatemeh Kaveh; Ole Christian Lingjærde; Rolf Kåresen; Torill Sauer; Vessela Kristensen; Anne-Lise Børresen-Dale; Per Morten Sandset; Nina Iversen
Journal:  Breast Cancer Res       Date:  2015-03-26       Impact factor: 6.466

3.  Platelet-primed interactions of coagulation and anticoagulation pathways in flow-dependent thrombus formation.

Authors:  Sanne L N Brouns; Johanna P van Geffen; Elena Campello; Frauke Swieringa; Paolo Simioni; Johan W M Heemskerk; Luca Spiezia; René van Oerle; Isabella Provenzale; Remco Verdoold; Richard W Farndale; Kenneth J Clemetson; Henri M H Spronk; Paola E J van der Meijden; Rachel Cavill; Marijke J E Kuijpers; Elisabetta Castoldi
Journal:  Sci Rep       Date:  2020-07-17       Impact factor: 4.379

4.  Association of SERPINC1 Gene Polymorphism (rs2227589) With Pulmonary Embolism Risk in a Chinese Population.

Authors:  Yongjian Yue; Qing Sun; Lu Xiao; Shengguo Liu; Qijun Huang; Minlian Wang; Mei Huo; Mo Yang; Yingyun Fu
Journal:  Front Genet       Date:  2019-09-13       Impact factor: 4.599

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.